Galectin-3 and risk of atrial fibrillation: A systematic review and meta-analysis.

Mengqi GongAngel CheungQun-Shan WangGuangping LiChristos A GoudisGeorge BazoukisGregory Y H LipAdrian BaranchukPanagiotis KorantzopoulosKonstantinos P LetsasGary Tse Tong Liu

Published in: Journal of clinical laboratory analysis (2020)

Our meta-analysis found that galectin-3 is significantly higher in patients with persistent AF than in those with paroxysmal AF, and can predict both AF development and recurrence after treatment.

Keyphrases

atrial fibrillation
catheter ablation
systematic review
oral anticoagulants
left atrial
left atrial appendage
direct oral anticoagulants
heart failure
percutaneous coronary intervention
meta analyses
randomized controlled trial
venous thromboembolism
case control
acute coronary syndrome
replacement therapy